首页> 外国专利> monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration.

monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration.

机译:抗rgm蛋白的单克隆抗体,用于治疗视网膜神经纤维层变性。

摘要

monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration. The present application describes rgm α-binding proteins, particularly monoclonal antibodies, and in particular humanized cdr-grafted versions thereof, which have the ability to bind rgm to and prevent the binding of rgm proteins to the rgm receptor and other rgm binding proteins. a, and therefore neutralize the function of rgm a, for use in treating retinal nerve fiber layer (cfnr) degeneration, as well as methods of therapeutic or prophylactic treatment of a mammal against cfnr degeneration.
机译:抗rgm蛋白的单克隆抗体,用于治疗视网膜神经纤维层变性。本申请描述了rgmα-结合蛋白,特别是单克隆抗体,特别是其人源化的cdr-移植形式,其具有将rgm结合到并防止rgm蛋白与rgm受体和其他rgm结合蛋白结合的能力。 a,因此中和rgm a的功能,用于治疗视网膜神经纤维层(cfnr)变性,以及针对cfnr变性的哺乳动物的治疗或预防方法。

著录项

  • 公开/公告号BR112012013734A2

    专利类型

  • 公开/公告日2017-01-10

    原文格式PDF

  • 申请/专利权人 ABBOTT GMBH & CO KG.;

    申请/专利号BR20121113734

  • 发明设计人 BERNHARD K. MUELLER;

    申请日2010-12-08

  • 分类号A61K39/395;C07K16/22;

  • 国家 BR

  • 入库时间 2022-08-21 13:40:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号